Respiratory News and Research

RSS

What we know about COVID-19 in children

A new viewpoint article published in the journal JAMA Pediatrics in April 2020 discusses the manifestation and management of the novel coronavirus disease devastating several countries.

7 Apr 2020

Individuals with celiac disease at increased risk of premature death

People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease in recent years and better access to gluten-free food.

7 Apr 2020

A special diet can help in certain cases of asthma, study suggests

Can a special diet help in certain cases of asthma? A new study at the University of Bonn at least points to this conclusion. According to the study, mice that were switched to a so-called ketogenic diet showed significantly reduced inflammation of the respiratory tract.

7 Apr 2020

Nursing homes have thousands of ventilators that hospitals desperately need

As the number of COVID-19 patients climbs and health officials hunt for ventilators to treat them, nursing homes across the United States have a cache - about 8,200 of the lifesaving machines, according to data from the Centers for Medicare & Medicaid Services.

7 Apr 2020

Researchers link celiac disease to increased risk of premature death

People with celiac disease have increased risk of dying prematurely, despite increased awareness of the disease recently.

7 Apr 2020

How do viruses mutate and jump to humans?

Zoonotic spillover events like the current novel coronavirus pandemic present threats to human health. But what is zoonotic spillover and how do they occur?

7 Apr 2020

Despite public health challenge, tobacco use continues to be overlooked

The number of tobacco smokers is projected to remain at around 1.1 billion until at least 2025, with 80 per cent of the world's smokers living in low- and middle-income countries (LMICs).

7 Apr 2020

Research reveals a potential 'chink in the armor' of SARS-CoV-2

The scientists from Scripps Research, reveal a likely vulnerability or weakness of the coronavirus. An antibody, called CR3022, recovered from a survivor of the SARS outbreak in 2002, has shown a potential vulnerability of the novel coronavirus.

6 Apr 2020

Tiger with SARS-CoV-2 infection demostrates reverse zoonosis

Some viruses come from animals and jump to humans to cause disease. In the case of the novel coronavirus, now known as the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), it is thought to have come from bats, jumped to an intermediate animal host, and then onto humans. But can the virus leap from humans to other animals?

6 Apr 2020

Antiparasitic drug Ivermectin kills coronavirus in 48 hours

Around the world, scientists race to develop a vaccine or treatment against the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Now, a team of researchers has found that a drug already available around the world can kill the coronavirus in a lab setting in just 48 hours.

6 Apr 2020

Researchers create algorithm to protect surgical team members from COVID-19

Researchers from Stanford University's department of surgery have created an algorithm that aims to protect operating room team members who perform urgent and emergency operations from Coronavirus Disease 2019 (COVID-19) and rationally conserve the personal protective equipment they wear.

6 Apr 2020

McMaster: Common medical masks are good for most COVID-19 treatment

The N95 respirator masks should be preserved for health-care workers involved in inserting breathing tubes for patients with COVID-19. More common medical masks are fine for all other COVID-19 treatment, says preliminary research from McMaster University.

6 Apr 2020

Rush participates in clinical trial to test remdesivir as potential treatment for COVID-19

Rush University Medical Center is participating in a new clinical trial to test the effectiveness of the drug remdesivir in the treatment of coronavirus disease 2019 (COVID-19). This disease currently has no approved treatment.

6 Apr 2020

Cranfield University helps design simple, low-cost ventilators for critically-ill COVID-19 patients

A simple, low-cost Bag Valve Mask (BVM) ventilator to help critically-ill COVID-19 patients has been rapidly designed by experts at Cranfield University (UK) and built in Georgia Tech (USA) in a matter of days.

6 Apr 2020

Should US schools close to thwart spread of COVID-19?

A new study used mathematical modeling to explore the benefits and risks of closing down the schools to prevent new cases and the possibility of absenteeism among health care workers because they need to care for their children at home and the ultimate effect of the step on reducing the risk of deaths due to COVID-19.

6 Apr 2020

Experimental drug APN01 prevents COVID-19 infection in the lab

With the world gripped with the COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), there is a frantic rush to find an effective drug that can be used to treat the disease.

6 Apr 2020

ATS releases new guidance to help clinicians manage COVID-19 patients

An American Thoracic Society-led international task force has released a guidance document to help clinicians manage COVID-19 patients in the face of a worldwide pandemic and minimal empirical evidence to guide treatment.

6 Apr 2020

Researchers investigate link between air pollution and SARS-CoV-2 lethality in Italy

The world has been hit hard by coronavirus, and health services and authorities everywhere are struggling to reduce the spread, combat the disease and protect the population. Nevertheless, the pandemic will cost lives throughout the world.

6 Apr 2020

DsbA-L gene may play a role in protecting respiratory function of the elderly

The lungs are constantly exposed to the external environment and maintain homeostasis by adapting to stress and tissue damage.

6 Apr 2020

Acute-19 becomes first bi-level turbine ventilator for patients affected by COVID-19

The first prototype of a bi-level turbine ventilator for pressure-monitored ventilation in patients affected by COVID-19, Acute-19, developed by Spanish researchers, has just successfully surpassed the validation phase in an animal model at the CEU Cardenal Herrera University of Valencia.

6 Apr 2020